These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34877074)

  • 41. Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm.
    Singh G; Tolkachjov SN; Farberg AS
    Clin Cosmet Investig Dermatol; 2023; 16():925-935. PubMed ID: 37051586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
    Eur J Cancer; 2023 Nov; 193():113251. PubMed ID: 37717283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
    Boutros A; Cecchi F; Tanda ET; Croce E; Gili R; Arecco L; Spagnolo F; Queirolo P
    Front Oncol; 2021; 11():733917. PubMed ID: 34513710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.
    Rentroia-Pacheco B; Tokez S; Bramer EM; Venables ZC; van de Werken HJG; Bellomo D; van Klaveren D; Mooyaart AL; Hollestein LM; Wakkee M
    EClinicalMedicine; 2023 Sep; 63():102150. PubMed ID: 37662519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical treatment of advanced cutaneous squamous-cell carcinoma.
    Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of sentinel lymphatic node biopsy in detection of early micrometastases in patients with cutaneous squamous cell carcinoma.
    Samsanavicius D; Kaikaris V; Cepas A; Ulrich J; Makstiene J; Rimdeika R
    J Plast Reconstr Aesthet Surg; 2018 Apr; 71(4):597-603. PubMed ID: 29174519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis.
    Smile TD; Xiong DX; Varra V; Winter IW; Beal BT; Gastman BR; Geiger JL; Adelstein DJ; Bergfeld WF; Piliang MP; Billings SD; Ko JS; Knackstedt TJ; Lucas JL; Poblete-Lopez CM; Meine JG; Vij A; Vidimos AT; Koyfman SA
    Anticancer Res; 2021 Jan; 41(1):289-295. PubMed ID: 33419823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
    Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
    JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma.
    Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O
    J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system.
    Dinehart SM; Peterson S
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1379-84. PubMed ID: 16416604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent Cutaneous Squamous Cell Carcinoma with Direct Invasion of the Pleura: A Case Report.
    Alkrekshi A; Mustafa M; Abdul-Al H; Brell J
    Cureus; 2019 Jul; 11(7):e5115. PubMed ID: 31523546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma.
    Aboul-Fettouh N; Morse D; Patel J; Migden MR
    Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021169S. PubMed ID: 34877077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Thariat J; Gorobets O; Vinh-Hung V; Kim L; Blanco SC; Vasileiou M; Arenas M; Mazibuko T; Giap H; Vincent F; Chi A; Loganadane G; Mohammadianpanah M; Rembielak A; Karlsson U; Ali A; Bose S; Page BR
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The Cutaneous Squamous Cell Carcinoma - An Update].
    Burda B; Schultz ES
    Laryngorhinootologie; 2023 Oct; 102(10):735-741. PubMed ID: 37054747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness.
    Khandelwal AR; Ma X; Egan P; Kaskas NM; Moore-Medlin T; Caldito G; Abreo F; Gu X; Aubrey L; Milligan E; Nathan CA
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):281-8. PubMed ID: 27095050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
    Ogata D; Tsuchida T
    Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab].
    Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF
    Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma.
    Krediet JT; Beyer M; Lenz K; Ulrich C; Lange-Asschenfeldt B; Stockfleth E; Terhorst D
    Br J Dermatol; 2015 Apr; 172(4):1029-36. PubMed ID: 25362868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.